Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Jan 14 2026

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-jan-14-2026-1

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call

Release

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 14, 2026, titled "Dr. Reddy s announces the first-to-market launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.".

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases